Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment

NCT02150733 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment
Solid Tumor
Cancer

Interventions

DRUG: Tivantinib
DRUG: Tivantinib
DRUG: Tivantinib
DRUG: Tivantinib

Sponsor

Daiichi Sankyo

Collaborators

[object Object]